Chargement en cours...
Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
The global emergency caused by COVID-19 makes the discovery of drugs capable of inhibiting SARS-CoV-2 a priority, to reduce the mortality and morbidity of this disease. Repurposing approved drugs can provide therapeutic alternatives that promise rapid and ample coverage because they have a documente...
Enregistré dans:
| Publié dans: | Comput Biol Chem |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier Ltd.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7316061/ https://ncbi.nlm.nih.gov/pubmed/32623357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.compbiolchem.2020.107325 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|